Our Services

Based in San Diego, CA, we provide management consulting and fractional leadership for the life sciences aligning strategy, systems, process, and execution to turn innovation into sustainable growth.

Go-to-Market Strategy & Launch Excellence

Comprehensive launch strategy that creates immediate market impact.

MAYA GTM Assessment: scores your team's alignment across the 11 critical dimensions of GTM and helps prioritize what to address first based on revenue risk exposure. Learn more
PRIYA Product-Market Fit and Commercial Readiness Validation: comprehensive, AI-augmented GTM audit powered by a 225-rule engine and deep domain expertise. Learn more
GAIA Comprehensive Go-To-Market Readiness Validation (includes PRIYA): evaluation of full GTM program across 13 critical dimensions, identifies gaps, risks, and misalignment, and delivers a prioritized roadmap so you can focus resources on the areas with the greatest commercial impact. Learn more
New product introduction (NPI) process development and ideal customer profiling
Value proposition creation, messaging frameworks, and competitive positioning
Pricing strategy development and distribution channel identification
Sales strategy design and go-to-market launch plan creation
Campaign playbook development with defined metrics and KPIs
End-to-end launch execution support from planning through market entry

Market Intelligence

Providing actionable information to life science companies.

Industry characterization and competitive landscape analysis to map the market terrain
Voice of customer studies and unmet needs analysis through primary market research
Top-down and bottom-up market modeling to quantify opportunity size and addressable segments
Revenue modeling using adoption curves built from survey data and historical proxies
Literature review and technical analyses to inform product positioning
Strategic insights synthesis, translating data into actionable recommendations

Capital Advisory

Strategic consulting on investor relations for life sciences and diagnostics companies.

Investor targeting, outreach programs, and non-deal roadshow facilitation
Quarterly earnings call script preparation and financial communications strategy
Compelling investor presentations, corporate decks, and fact sheet development
Financial modeling, valuation analysis, and competitive market positioning
Crisis communication and shareholder trust management
C-suite training on investor communication best practices and media relations

Commercial Due Diligence

Investor-grade assessment of a target's go-to-market program, delivered on deal timelines.

GAIA: evaluation across 13 GTM dimensions with a prioritized risk roadmap, so commercial assumptions in the model can be tested against evidence rather than narrative. Learn more
PRIYA: product-market fit and commercial readiness validation via a 225-rule engine. Because scoring is deterministic, the same inputs produce the same findings regardless of who commissioned the assessment. Learn more

Regulatory Affairs &
Quality Assurance

Regulatory and quality pathways for companies preparing for commercialization.

Scalable QMS design and implementation aligned with ISO 13485, FDA QSR, and global standards
FDA, Health Canada, EU MDR/IVDR, and TGA filing preparation to accelerate market access
Regulatory strategy for AI-powered and software-based medical devices (SaMD)
Gap assessments, audit readiness, and supplier qualification programs
Post-market surveillance and vigilance to maintain product compliance
Leadership coaching on regulatory readiness, inspection prep, and quality culture